Literature DB >> 17057216

Helminths and mucosal immune modulation.

Joel V Weinstock1.   

Abstract

Geographic and ethnic variations in ulcerative colitis and Crohn's disease frequency suggest that environmental factors affect disease risk. Prevention of parasitic worms (helminths) through improved hygiene may be one factor leading to the increased disease prevalence. Helminths alter host mucosal and systemic immunity. Animals exposed to helminths are protected from experimental colitis and other immunological diseases, and helminthic colonization can be used to treat ongoing murine and human disease. Helminths induce mucosal T cells to make Th2 and regulatory cytokines. Helminth-induced mucosal IL4, TGFbeta, and IL10 likely are part of the protective process. Helminths affect pathways of innate immunity like TLR4 expression and function. Worms also induce various regulatory-type T-cell subsets in the gut that limit effector T-cell growth and function. These effects of once ever-present helminths may have protected people from immune-mediated illnesses like inflammatory bowel disease.

Entities:  

Mesh:

Year:  2006        PMID: 17057216     DOI: 10.1196/annals.1326.033

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  24 in total

Review 1.  The use of Trichuris suis and other helminth therapies to treat Crohn's disease.

Authors:  Aditya Reddy; Bernard Fried
Journal:  Parasitol Res       Date:  2007-01-06       Impact factor: 2.289

2.  A long noncoding RNA signature for ulcerative colitis identifies IFNG-AS1 as an enhancer of inflammation.

Authors:  David Padua; Swapna Mahurkar-Joshi; Ivy Ka Man Law; Christos Polytarchou; John P Vu; Joseph R Pisegna; David Shih; Dimitrios Iliopoulos; Charalabos Pothoulakis
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-04       Impact factor: 4.052

Review 3.  Interactions between the host innate immune system and microbes in inflammatory bowel disease.

Authors:  Clara Abraham; Ruslan Medzhitov
Journal:  Gastroenterology       Date:  2011-05       Impact factor: 22.682

4.  The intraperitoneal inoculation of Lactobacillus casei in mice induces total protection against Trichinella spiralis infection at low challenge doses.

Authors:  Federico Martínez-Gómez; Beatriz Eugenia Fuentes-Castro; Carlos Ramón Bautista-Garfias
Journal:  Parasitol Res       Date:  2011-05-04       Impact factor: 2.289

Review 5.  The fundamental basis of inflammatory bowel disease.

Authors:  Warren Strober; Ivan Fuss; Peter Mannon
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

Review 6.  Adenosine: an immune modulator of inflammatory bowel diseases.

Authors:  Jeff Huaqing Ye; Vazhaikkurichi M Rajendran
Journal:  World J Gastroenterol       Date:  2009-09-28       Impact factor: 5.742

Review 7.  Inflammatory bowel disease.

Authors:  Clara Abraham; Judy H Cho
Journal:  N Engl J Med       Date:  2009-11-19       Impact factor: 91.245

8.  Imperatorin Relieved Ulcerative Colitis by Regulating the Nrf-2/ARE/HO-1 Pathway in Rats.

Authors:  Min Luo; Yin Luo
Journal:  Inflammation       Date:  2020-10-23       Impact factor: 4.092

Review 9.  Aberrant immune response with consequent vascular and connective tissue remodeling - causal to scleroderma and associated syndromes such as Raynaud phenomenon and other fibrosing syndromes?

Authors:  Nedim Durmus; Sung-Hyun Park; Joan Reibman; Gabriele Grunig
Journal:  Curr Opin Rheumatol       Date:  2016-11       Impact factor: 5.006

Review 10.  Helminth infections and intestinal inflammation.

Authors:  Li Jian Wang; Yue Cao; Hai Ning Shi
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.